Bio-Rad Laboratories (BIO.B) to Release Earnings on Tuesday

Bio-Rad Laboratories (NYSE:BIO.BGet Free Report) is scheduled to post its quarterly earnings results after the market closes on Tuesday, May 7th. Individual that wish to register for the company’s earnings conference call can do so using this link.

Bio-Rad Laboratories (NYSE:BIO.BGet Free Report) last released its earnings results on Thursday, February 15th. The company reported $3.10 earnings per share (EPS) for the quarter. The company had revenue of $681.18 million for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.90% and a negative net margin of 23.86%.

Bio-Rad Laboratories Price Performance

BIO.B stock opened at $279.91 on Friday. Bio-Rad Laboratories has a 52 week low of $271.00 and a 52 week high of $467.95. The business has a 50-day simple moving average of $320.27 and a 200 day simple moving average of $314.95. The company has a quick ratio of 4.34, a current ratio of 5.83 and a debt-to-equity ratio of 0.14. The company has a market cap of $7.98 billion, a PE ratio of -13.03 and a beta of 0.70.

About Bio-Rad Laboratories

(Get Free Report)

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

Featured Stories

Earnings History for Bio-Rad Laboratories (NYSE:BIO.B)

Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.